LAMOTRIGINE EXTENDED-RELEASE

LAMOTRIGINE EXTENDED-RELEASE was reported 72847 times

LAMOTRIGINE EXTENDED-RELEASE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NEW ONSET REFRACTORY STATUS EPILEPTICUS 46 0.4182
1 POSTICTAL PSYCHOSIS 46 0.2949
2 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 128 0.2393
3 HYPOCHOLESTEROLAEMIA 62 0.1756
4 OVERLAP SYNDROME 118 0.1686
5 MULTIPLE-DRUG RESISTANCE 521 0.1678
6 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 65 0.1389
7 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 80 0.1231
8 DEVELOPMENTAL HIP DYSPLASIA 97 0.1166
9 TOXIC OPTIC NEUROPATHY 49 0.1129
10 SJS-TEN OVERLAP 79 0.1125
11 SELECTIVE EATING DISORDER 99 0.1088
12 FOCAL DYSCOGNITIVE SEIZURES 122 0.1071
13 PLEUROTHOTONUS 93 0.1029
14 MYOCLONIC EPILEPSY 155 0.1021
15 EXOMPHALOS 53 0.0987
16 EOSINOPHILIC MYOCARDITIS 69 0.0945
17 CHANGE IN SEIZURE PRESENTATION 60 0.0927
18 HYPOSPADIAS 193 0.0927
19 BRUGADA SYNDROME 95 0.0918
20 ANTICONVULSANT DRUG LEVEL DECREASED 129 0.0913
21 COARCTATION OF THE AORTA 87 0.0901
22 SPINA BIFIDA 185 0.0887
23 ATONIC SEIZURES 76 0.0885
24 RESPIRATORY DISORDER NEONATAL 141 0.0869
25 FACET JOINT SYNDROME 278 0.0853
26 POLYDACTYLY 98 0.0845
27 AGITATION NEONATAL 80 0.0834
28 INFANTILE APNOEA 66 0.0809
29 ANTICONVULSANT DRUG LEVEL INCREASED 130 0.0804
30 PETIT MAL EPILEPSY 410 0.0802
31 DYSMORPHISM 189 0.0802
32 DYSMETRIA 48 0.0795
33 LIP EROSION 56 0.0767
34 FOETAL ANTICONVULSANT SYNDROME 89 0.0750
35 TONIC CONVULSION 105 0.0740
36 LUPUS VULGARIS 93 0.0738
37 SYNDACTYLY 61 0.0734
38 CLEFT LIP AND PALATE 82 0.0733
39 FOETAL MALFORMATION 79 0.0727
40 FEEDING DISORDER NEONATAL 76 0.0727
41 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1840 0.0714
42 PYLORIC STENOSIS 59 0.0697
43 INFUSION SITE REACTION 208 0.0696
44 PERIPHERAL VENOUS DISEASE 279 0.0682
45 GENERALISED TONIC-CLONIC SEIZURE 1122 0.0677
46 SEIZURE CLUSTER 56 0.0676
47 PARTIAL SEIZURES 352 0.0671
48 COMPLEX PARTIAL SEIZURES 74 0.0665
49 NYSTAGMUS 352 0.0663
50 BRADYCARDIA NEONATAL 82 0.0652
51 OCULOGYRIC CRISIS 140 0.0652
52 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 49 0.0651
53 STATUS EPILEPTICUS 733 0.0648
54 ATAXIA 768 0.0646
55 BEZOAR 88 0.0638
56 TOXIC EPIDERMAL NECROLYSIS 968 0.0637
57 EPILEPSY 1945 0.0636
58 BLEPHAROSPASM 396 0.0628
59 SOFT TISSUE INJURY 47 0.0621
60 SUSPECTED SUICIDE 291 0.0620
61 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 315 0.0614
62 AURA 113 0.0605
63 HYPOTONIA NEONATAL 93 0.0595
64 CLEFT PALATE 115 0.0595
65 STEVENS-JOHNSON SYNDROME 1303 0.0586
66 ATRIAL SEPTAL DEFECT 490 0.0585
67 THERAPEUTIC PRODUCT CROSS-REACTIVITY 51 0.0571
68 MICROCEPHALY 73 0.0569
69 ORAL MUCOSA EROSION 69 0.0561
70 INTELLECTUAL DISABILITY 83 0.0546
71 DISLOCATION OF VERTEBRA 121 0.0530
72 VENTRICULAR SEPTAL DEFECT 300 0.0523
73 ONYCHOMADESIS 218 0.0519
74 PATENT DUCTUS ARTERIOSUS 206 0.0518
75 TALIPES 160 0.0515
76 HYPERREFLEXIA 173 0.0496
77 ELECTROENCEPHALOGRAM ABNORMAL 155 0.0490
78 HYPOMANIA 180 0.0489
79 GAZE PALSY 81 0.0475
80 EXPOSURE VIA BREAST MILK 186 0.0467
81 RHEUMATIC FEVER 206 0.0462
82 CLONUS 126 0.0460
83 BREAST CANCER STAGE III 297 0.0458
84 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 146 0.0449
85 TONIC CLONIC MOVEMENTS 58 0.0446
86 MATERNAL EXPOSURE DURING BREAST FEEDING 181 0.0446
87 MATERNAL DRUGS AFFECTING FOETUS 332 0.0433
88 RASH MORBILLIFORM 120 0.0432
89 STERNAL FRACTURE 52 0.0421
90 RETINITIS 72 0.0416
91 EXCESSIVE EYE BLINKING 61 0.0412
92 PSYCHOMOTOR RETARDATION 116 0.0412
93 DRUG LEVEL INCREASED 664 0.0401
94 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 297 0.0395
95 DUODENAL ULCER PERFORATION 287 0.0386
96 ANTIPSYCHOTIC DRUG LEVEL INCREASED 108 0.0383
97 BEHAVIOUR DISORDER 206 0.0380
98 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 158 0.0380
99 CEREBELLAR SYNDROME 83 0.0378
100 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 271 0.0378
101 SEIZURE 4360 0.0377
102 BIPOLAR I DISORDER 82 0.0373
103 COMPLETED SUICIDE 3096 0.0371
104 DEEP VEIN THROMBOSIS POSTOPERATIVE 74 0.0369
105 X-RAY ABNORMAL 66 0.0369
106 MULTIPLE CONGENITAL ABNORMALITIES 53 0.0368
107 MYOCLONUS 436 0.0365
108 LIVE BIRTH 300 0.0358
109 PSYCHOTIC SYMPTOM 73 0.0353
110 NEONATAL RESPIRATORY DISTRESS SYNDROME 124 0.0350
111 BIPOLAR DISORDER 377 0.0346
112 SMALL FOR DATES BABY 172 0.0346
113 WRONG PATIENT RECEIVED PRODUCT 101 0.0345
114 FOETAL EXPOSURE DURING PREGNANCY 2803 0.0344
115 SEROTONIN SYNDROME 658 0.0342
116 OBSESSIVE THOUGHTS 61 0.0338
117 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 69 0.0333
118 ILLUSION 55 0.0332
119 CATAPLEXY 47 0.0332
120 DEPRESSIVE SYMPTOM 116 0.0329
121 INAPPROPRIATE AFFECT 52 0.0328
122 SWOLLEN JOINT COUNT INCREASED 103 0.0323
123 PERSONALITY DISORDER 84 0.0320
124 FOLLICULITIS 335 0.0319
125 GRAND MAL CONVULSION 292 0.0316
126 OBSESSIVE-COMPULSIVE DISORDER 253 0.0315
127 CONGENITAL ANOMALY 244 0.0315
128 COMA SCALE ABNORMAL 91 0.0314
129 DISTRIBUTIVE SHOCK 71 0.0313
130 INTENTIONAL SELF-INJURY 625 0.0309
131 MUSCLE INJURY 254 0.0306
132 HYPERCHOLESTEROLAEMIA 293 0.0303
133 STARING 72 0.0298
134 PSYCHOMOTOR SKILLS IMPAIRED 78 0.0297
135 PERSECUTORY DELUSION 74 0.0296
136 MENINGITIS ASEPTIC 132 0.0294
137 INTENTIONAL OVERDOSE 1876 0.0292
138 DRUG WITHDRAWAL CONVULSIONS 52 0.0292
139 LIBIDO INCREASED 59 0.0291
140 BACK INJURY 313 0.0288
141 MANIA 473 0.0287
142 CEREBRAL ATROPHY 114 0.0286
143 HOSTILITY 72 0.0283
144 SPEECH DISORDER DEVELOPMENTAL 81 0.0282
145 DISORGANISED SPEECH 52 0.0282
146 CONJUNCTIVAL HYPERAEMIA 98 0.0275
147 HYPERAMMONAEMIA 135 0.0270
148 NEUROLEPTIC MALIGNANT SYNDROME 318 0.0268
149 BURSITIS 324 0.0267
150 POISONING DELIBERATE 252 0.0266
151 EXPOSURE VIA INGESTION 66 0.0261
152 LIP DRY 236 0.0260
153 STRABISMUS 76 0.0258
154 CONVULSION 1470 0.0257
155 RASH MACULO-PAPULAR 570 0.0256
156 HELICOBACTER INFECTION 260 0.0253
157 BONE EROSION 89 0.0251
158 TEMPERATURE REGULATION DISORDER 56 0.0251
159 TACHYPHRENIA 86 0.0248
160 TONGUE BITING 51 0.0247
161 SUICIDE ATTEMPT 1498 0.0247
162 STILLBIRTH 119 0.0246
163 DRUG DOSE TITRATION NOT PERFORMED 45 0.0245
164 TOXICITY TO VARIOUS AGENTS 4055 0.0240
165 CLUMSINESS 65 0.0238
166 CATATONIA 125 0.0238
167 DRUG TITRATION ERROR 61 0.0236
168 AUTISM SPECTRUM DISORDER 130 0.0236
169 OBESITY 370 0.0232
170 FINE MOTOR SKILL DYSFUNCTION 67 0.0231
171 GAMBLING DISORDER 62 0.0229
172 RESPIRATORY ACIDOSIS 90 0.0229
173 PARADOXICAL DRUG REACTION 84 0.0228
174 HYPOGAMMAGLOBULINAEMIA 149 0.0227
175 SLOW SPEECH 55 0.0226
176 HEPATOSPLENOMEGALY 58 0.0226
177 POISONING 283 0.0225
178 NORMAL NEWBORN 122 0.0224
179 IMPULSIVE BEHAVIOUR 84 0.0224
180 SUICIDAL BEHAVIOUR 93 0.0223
181 WOUND INFECTION 241 0.0220
182 LEARNING DISORDER 53 0.0220
183 EXPOSURE DURING PREGNANCY 1343 0.0216
184 LOGORRHOEA 76 0.0215
185 RASH VESICULAR 103 0.0213
186 NAIL DISORDER 185 0.0211
187 SEDATION 553 0.0211
188 AGGRESSION 1055 0.0211
189 ELECTRIC SHOCK SENSATION 59 0.0211
190 ANXIETY DISORDER 70 0.0209
191 STUPOR 67 0.0208
192 DRUG INTERACTION 3308 0.0208
193 BRADYPNOEA 56 0.0207
194 GESTATIONAL DIABETES 98 0.0205
195 PEMPHIGUS 256 0.0205
196 PRODUCT SUBSTITUTION ISSUE 1172 0.0203
197 HYPERTONIA 116 0.0202
198 FLAT AFFECT 46 0.0199
199 MATERNAL EXPOSURE DURING PREGNANCY 1768 0.0198
200 BLOOD PROLACTIN INCREASED 93 0.0197
201 HYPERTHERMIA 150 0.0196
202 SELF-INJURIOUS IDEATION 82 0.0195
203 DRUG LEVEL DECREASED 198 0.0194
204 DRUG TOLERANCE 98 0.0194
205 EXPOSURE DURING BREAST FEEDING 64 0.0193
206 PERICARDITIS 324 0.0193
207 HAEMATOLOGICAL INFECTION 47 0.0192
208 HAND DEFORMITY 252 0.0192
209 AFFECTIVE DISORDER 150 0.0191
210 HALLUCINATION, AUDITORY 300 0.0189
211 DIPLOPIA 488 0.0188
212 HYPERNATRAEMIA 93 0.0186
213 HALLUCINATIONS, MIXED 78 0.0185
214 COORDINATION ABNORMAL 258 0.0185
215 DRUG EXPOSURE DURING PREGNANCY 627 0.0184
216 EXOSTOSIS 168 0.0184
217 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 48 0.0183
218 BUNDLE BRANCH BLOCK RIGHT 84 0.0183
219 PARKINSONISM 177 0.0181
220 HYPOTONIA 181 0.0181
221 ABORTION INDUCED 168 0.0178
222 DRUG SCREEN FALSE POSITIVE 49 0.0177
223 ERYTHEMA MULTIFORME 165 0.0177
224 SINUS TACHYCARDIA 251 0.0177
225 AKATHISIA 241 0.0176
226 AREFLEXIA 47 0.0176
227 DRUG ERUPTION 312 0.0176
228 TIC 96 0.0176
229 TASTE DISORDER 357 0.0176
230 COMA 837 0.0176
231 JOINT RANGE OF MOTION DECREASED 235 0.0175
232 PSYCHIATRIC SYMPTOM 129 0.0175
233 CARDIO-RESPIRATORY ARREST 730 0.0174
234 ABORTION SPONTANEOUS 697 0.0174
235 HEPATIC NECROSIS 65 0.0172
236 DELUSION 268 0.0172
237 SUICIDAL IDEATION 1579 0.0172
238 MAJOR DEPRESSION 126 0.0172
239 MULTIPLE DRUG OVERDOSE INTENTIONAL 55 0.0171
240 GLOSSODYNIA 382 0.0170
241 SNORING 64 0.0169
242 MUSCLE RIGIDITY 202 0.0169
243 FEELING DRUNK 125 0.0168
244 DRUG LEVEL ABOVE THERAPEUTIC 77 0.0168
245 DRUG RESISTANCE 431 0.0168
246 MYDRIASIS 215 0.0167
247 ELECTROCARDIOGRAM QT PROLONGED 599 0.0166
248 PSYCHOTIC DISORDER 491 0.0166
249 DEVELOPMENTAL DELAY 148 0.0164
250 SYNOVITIS 294 0.0163
251 PSYCHOMOTOR HYPERACTIVITY 270 0.0163
252 GRIP STRENGTH DECREASED 143 0.0162
253 AGITATION 1193 0.0162
254 EYE MOVEMENT DISORDER 111 0.0162
255 ENCEPHALOPATHY 398 0.0162
256 CONCUSSION 124 0.0160
257 IRRITABLE BOWEL SYNDROME 343 0.0160
258 DECREASED INTEREST 94 0.0159
259 POLYDIPSIA 63 0.0159
260 APNOEA 124 0.0159
261 ENURESIS 64 0.0158
262 HISTIOCYTOSIS HAEMATOPHAGIC 47 0.0158
263 SALIVARY HYPERSECRETION 158 0.0158
264 POSTURE ABNORMAL 51 0.0157
265 EOSINOPHILIA 273 0.0156
266 OVERWEIGHT 83 0.0154
267 DISSOCIATION 118 0.0154
268 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 157 0.0153
269 PRODUCT ADMINISTRATION INTERRUPTED 120 0.0153
270 ALTERED STATE OF CONSCIOUSNESS 330 0.0152
271 DROOLING 105 0.0152
272 RED BLOOD CELL SEDIMENTATION RATE INCREASED 167 0.0151
273 FEELING OF DESPAIR 70 0.0150
274 PRE-ECLAMPSIA 71 0.0149
275 COGNITIVE DISORDER 696 0.0149
276 HYPERPHAGIA 59 0.0148
277 HALLUCINATION, VISUAL 311 0.0147
278 HEART DISEASE CONGENITAL 52 0.0147
279 CAESAREAN SECTION 171 0.0147
280 HYPERACUSIS 54 0.0145
281 MUSCLE TWITCHING 332 0.0144
282 LYMPHADENOPATHY 508 0.0143
283 HAEMODYNAMIC INSTABILITY 109 0.0143
284 ANGER 481 0.0142
285 ORAL DISORDER 104 0.0142
286 IRRITABILITY 853 0.0142
287 PARANOIA 244 0.0141
288 MATERNAL EXPOSURE BEFORE PREGNANCY 96 0.0140
289 UNRESPONSIVE TO STIMULI 362 0.0140
290 APATHY 204 0.0140
291 DEPRESSED LEVEL OF CONSCIOUSNESS 548 0.0138
292 ATTENTION DEFICIT HYPERACTIVITY DISORDER 58 0.0138
293 LOW BIRTH WEIGHT BABY 109 0.0137
294 SOPOR 181 0.0136
295 FIBROMYALGIA 332 0.0136
296 DYSARTHRIA 513 0.0136
297 TOXIC ENCEPHALOPATHY 69 0.0136
298 C-REACTIVE PROTEIN INCREASED 495 0.0136
299 AFFECT LABILITY 130 0.0135
300 PUSTULAR PSORIASIS 46 0.0134
301 LIVER FUNCTION TEST INCREASED 287 0.0134
302 RHEUMATOID FACTOR POSITIVE 77 0.0133
303 DISTURBANCE IN ATTENTION 714 0.0132
304 SOMNOLENCE 2629 0.0130
305 DEPRESSION SUICIDAL 45 0.0130
306 ONYCHOMYCOSIS 57 0.0130
307 SOCIAL AVOIDANT BEHAVIOUR 75 0.0129
308 THERAPEUTIC RESPONSE CHANGED 82 0.0129
309 ABNORMAL BEHAVIOUR 509 0.0128
310 TOXIC SKIN ERUPTION 129 0.0128
311 BRUXISM 69 0.0128
312 MENTAL IMPAIRMENT 309 0.0127
313 LIVER INJURY 312 0.0127
314 DRUG LEVEL BELOW THERAPEUTIC 70 0.0127
315 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 86 0.0126
316 MOOD SWINGS 399 0.0125
317 MATERNAL EXPOSURE TIMING UNSPECIFIED 47 0.0125
318 BLISTER 700 0.0125
319 DYSKINESIA 506 0.0124
320 CEREBRAL DISORDER 92 0.0124
321 SELF-MEDICATION 51 0.0124
322 PAPULE 87 0.0123
323 ACUTE HEPATIC FAILURE 168 0.0123
324 BUNDLE BRANCH BLOCK LEFT 52 0.0122
325 BREAST CANCER STAGE II 102 0.0122
326 SCREAMING 78 0.0122
327 URINARY TRACT DISORDER 55 0.0122
328 PRE-EXISTING CONDITION IMPROVED 76 0.0122
329 MOOD ALTERED 332 0.0122
330 FACE OEDEMA 205 0.0121
331 RESPIRATORY ARREST 334 0.0121
332 MIOSIS 97 0.0121
333 NIGHT SWEATS 389 0.0121
334 DRUG-INDUCED LIVER INJURY 377 0.0120
335 DELIRIUM 414 0.0119
336 HYPERVENTILATION 69 0.0119
337 DISSEMINATED INTRAVASCULAR COAGULATION 167 0.0118
338 THINKING ABNORMAL 221 0.0118
339 INFARCTION 81 0.0118
340 LUPUS-LIKE SYNDROME 107 0.0118
341 GAIT INABILITY 394 0.0118
342 AMMONIA INCREASED 60 0.0117
343 CONTRAINDICATED PRODUCT ADMINISTERED 356 0.0117
344 RESTLESSNESS 430 0.0117
345 STRESS CARDIOMYOPATHY 68 0.0117
346 FOETAL GROWTH RESTRICTION 71 0.0117
347 MYOCARDITIS 133 0.0116
348 RESPIRATORY DEPRESSION 142 0.0116
349 MENTAL STATUS CHANGES 321 0.0115
350 PERSONALITY CHANGE 107 0.0115
351 ATRIOVENTRICULAR BLOCK COMPLETE 77 0.0115
352 PULSELESS ELECTRICAL ACTIVITY 48 0.0115
353 GENERALISED ERYTHEMA 65 0.0114
354 BRADYKINESIA 67 0.0113
355 HOMICIDAL IDEATION 46 0.0113
356 APHASIA 340 0.0112
357 BALANCE DISORDER 971 0.0112
358 ODYNOPHAGIA 67 0.0112
359 PHOTOPHOBIA 211 0.0112
360 SCHIZOPHRENIA 135 0.0111
361 DEPRESSED MOOD 583 0.0110
362 CARDIAC ARREST 909 0.0110
363 PRESCRIBED OVERDOSE 213 0.0110
364 TYPE 2 DIABETES MELLITUS 370 0.0110
365 CONFUSIONAL STATE 1773 0.0110
366 APLASTIC ANAEMIA 57 0.0109
367 IMPAIRED HEALING 358 0.0109
368 POST-TRAUMATIC STRESS DISORDER 73 0.0109
369 SOMNAMBULISM 71 0.0108
370 PRODUCT LABEL CONFUSION 63 0.0108
371 DEPRESSION 2458 0.0108
372 PREGNANCY 216 0.0108
373 DISORIENTATION 425 0.0107
374 WOUND 299 0.0107
375 LEUKOCYTOSIS 193 0.0107
376 CONJUNCTIVITIS 196 0.0106
377 SLEEP DISORDER 744 0.0105
378 VENTRICULAR FIBRILLATION 117 0.0105
379 ACIDOSIS 80 0.0105
380 DYSTONIA 203 0.0105
381 CHEILITIS 56 0.0103
382 PREMATURE BABY 310 0.0103
383 AUTOIMMUNE DISORDER 100 0.0102
384 NEUTROPHILIA 58 0.0102
385 ULCER HAEMORRHAGE 69 0.0102
386 AGRANULOCYTOSIS 189 0.0102
387 TREMOR 1677 0.0101
388 SYSTEMIC LUPUS ERYTHEMATOSUS 356 0.0100
389 DERMATITIS EXFOLIATIVE 50 0.0100
390 BRAIN OEDEMA 126 0.0100
391 MOTOR DYSFUNCTION 101 0.0099
392 HYPOVOLAEMIC SHOCK 47 0.0098
393 MULTIPLE ORGAN DYSFUNCTION SYNDROME 277 0.0098
394 HYPERTRANSAMINASAEMIA 68 0.0098
395 TREATMENT FAILURE 805 0.0097
396 NEUTROPHIL COUNT INCREASED 99 0.0097
397 C-REACTIVE PROTEIN ABNORMAL 62 0.0097
398 RHABDOMYOLYSIS 402 0.0096
399 MOUTH ULCERATION 203 0.0096
400 PNEUMONIA ASPIRATION 240 0.0096
401 HYPERSOMNIA 275 0.0096
402 ACUTE RESPIRATORY DISTRESS SYNDROME 169 0.0095
403 DYSPHORIA 48 0.0095
404 PRESCRIBED UNDERDOSE 189 0.0095
405 DRUG TOXICITY 129 0.0095
406 PSORIATIC ARTHROPATHY 384 0.0095
407 SLEEP APNOEA SYNDROME 180 0.0094
408 MEMORY IMPAIRMENT 1292 0.0094
409 HYPOTHERMIA 95 0.0094
410 PURPURA 83 0.0094
411 BODY TEMPERATURE INCREASED 191 0.0094
412 TRANSAMINASES INCREASED 207 0.0093
413 ELECTROCARDIOGRAM ABNORMAL 73 0.0093
414 CRYING 338 0.0093
415 NEUROLOGICAL SYMPTOM 53 0.0093
416 AMNESIA 602 0.0092
417 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 158 0.0092
418 SINUS BRADYCARDIA 89 0.0092
419 BRADYPHRENIA 60 0.0092
420 ATRIOVENTRICULAR BLOCK 71 0.0092
421 RASH GENERALISED 237 0.0091
422 EXTRAPYRAMIDAL DISORDER 227 0.0091
423 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 71 0.0091
424 WITHDRAWAL SYNDROME 383 0.0091
425 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 648 0.0091
426 VERTIGO 554 0.0091
427 THERAPEUTIC PRODUCT EFFECT DECREASED 407 0.0091
428 EUPHORIC MOOD 93 0.0091
429 MENTAL DISORDER 394 0.0090
430 PREMATURE LABOUR 51 0.0090
431 RESTLESS LEGS SYNDROME 164 0.0090
432 LETHARGY 517 0.0090
433 BLOOD CREATINE PHOSPHOKINASE INCREASED 258 0.0090
434 WALKING AID USER 59 0.0089
435 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 79 0.0089
436 HYPONATRAEMIA 501 0.0089
437 FOETAL DEATH 46 0.0089
438 ASPIRATION 97 0.0088
439 NIGHTMARE 304 0.0088
440 TACHYCARDIA 778 0.0087
441 DERMATITIS ALLERGIC 110 0.0087
442 WRONG PRODUCT ADMINISTERED 59 0.0087
443 DERMATITIS BULLOUS 63 0.0087
444 DRUG ABUSE 723 0.0087
445 TORSADE DE POINTES 68 0.0087
446 HEPATIC ENZYME INCREASED 588 0.0086
447 TACHYPNOEA 117 0.0086
448 ANURIA 74 0.0086
449 BLOOD LACTIC ACID INCREASED 45 0.0085
450 PREMATURE DELIVERY 136 0.0085
451 URINARY INCONTINENCE 253 0.0085
452 SHOCK 196 0.0085
453 IMPAIRED GASTRIC EMPTYING 116 0.0085
454 INCOHERENT 55 0.0085
455 EAR PAIN 165 0.0085
456 INITIAL INSOMNIA 87 0.0085
457 MIDDLE INSOMNIA 158 0.0085
458 VITAMIN D DEFICIENCY 82 0.0084
459 RASH ERYTHEMATOUS 401 0.0084
460 GASTROOESOPHAGEAL REFLUX DISEASE 675 0.0084
461 HYPERTRIGLYCERIDAEMIA 49 0.0084
462 PANIC ATTACK 305 0.0084
463 SPEECH DISORDER 437 0.0083
464 MIGRAINE 792 0.0083
465 HYPOALBUMINAEMIA 64 0.0082
466 BLOOD CHOLESTEROL INCREASED 383 0.0082
467 CARDIAC MURMUR 71 0.0082
468 DYSGRAPHIA 54 0.0082
469 ARTERIOSCLEROSIS CORONARY ARTERY 54 0.0081
470 SUDDEN DEATH 86 0.0081
471 RASH PAPULAR 182 0.0081
472 BRAIN FOG 127 0.0081
473 GAMMA-GLUTAMYLTRANSFERASE INCREASED 178 0.0080
474 OVERDOSE 1728 0.0080
475 IMPAIRED DRIVING ABILITY 91 0.0080
476 PHOTOSENSITIVITY REACTION 132 0.0080
477 POOR QUALITY SLEEP 172 0.0080
478 THERAPY NON-RESPONDER 354 0.0079
479 INCREASED APPETITE 150 0.0078
480 DRUG SCREEN POSITIVE 62 0.0078
481 NEUTROPENIC SEPSIS 56 0.0078
482 TREATMENT NONCOMPLIANCE 429 0.0078
483 THERAPY PARTIAL RESPONDER 122 0.0078
484 NEUROTOXICITY 137 0.0078
485 OSTEOARTHRITIS 331 0.0078
486 MEDICATION ERROR 433 0.0078
487 CONDITION AGGRAVATED 2358 0.0077
488 DRY MOUTH 629 0.0077
489 ANXIETY 2199 0.0077
490 METABOLIC ACIDOSIS 247 0.0077
491 HYPERPROLACTINAEMIA 50 0.0077
492 COELIAC DISEASE 75 0.0076
493 CARDIOTOXICITY 68 0.0076
494 NECK PAIN 426 0.0076
495 HEPATOCELLULAR INJURY 107 0.0075
496 HEAD INJURY 238 0.0075
497 TARDIVE DYSKINESIA 212 0.0075
498 VENTRICULAR TACHYCARDIA 124 0.0075
499 HALLUCINATION 562 0.0074
500 CARDIOGENIC SHOCK 106 0.0074
501 STOMATITIS 448 0.0074
502 BRAIN INJURY 74 0.0074
503 INFLAMMATION 378 0.0073
504 JOINT DISLOCATION 77 0.0073
505 HYDRONEPHROSIS 54 0.0072
506 IMPAIRED WORK ABILITY 153 0.0072
507 CIRCULATORY COLLAPSE 121 0.0071
508 FEAR 190 0.0071
509 RESPIRATORY RATE INCREASED 62 0.0070
510 DRUG INTOLERANCE 674 0.0070
511 LOSS OF CONSCIOUSNESS 890 0.0069
512 TUBULOINTERSTITIAL NEPHRITIS 130 0.0069
513 BRADYCARDIA 367 0.0069
514 CENTRAL NERVOUS SYSTEM LESION 95 0.0069
515 RASH MACULAR 239 0.0068
516 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 373 0.0068
517 RASH 2945 0.0067
518 LOWER LIMB FRACTURE 129 0.0067
519 EYELID OEDEMA 78 0.0067
520 PHARYNGITIS 83 0.0067
521 ENCEPHALITIS 46 0.0066
522 SKIN LESION 182 0.0066
523 WHITE BLOOD CELL COUNT INCREASED 254 0.0066
524 LEUKOPENIA 331 0.0066
525 EMOTIONAL DISORDER 204 0.0066
526 ACCIDENTAL OVERDOSE 238 0.0065
527 GAIT DISTURBANCE 1243 0.0065
528 LUNG DISORDER 318 0.0065
529 ALANINE AMINOTRANSFERASE INCREASED 398 0.0065
530 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 110 0.0065
531 LOWER RESPIRATORY TRACT INFECTION 294 0.0065
532 SCIATICA 103 0.0065
533 INABILITY TO AFFORD MEDICATION 64 0.0064
534 TROPONIN INCREASED 49 0.0064
535 HEPATIC CYTOLYSIS 82 0.0064
536 SUBSTANCE ABUSE 52 0.0064
537 HEMIPLEGIA 53 0.0064
538 HEPATITIS 163 0.0064
539 VISUAL FIELD DEFECT 46 0.0064
540 DRUG DISPENSING ERROR 96 0.0063
541 ECONOMIC PROBLEM 95 0.0063
542 SKIN REACTION 88 0.0062
543 INCONTINENCE 66 0.0062
544 EOSINOPHIL COUNT INCREASED 52 0.0062
545 ANAL INCONTINENCE 56 0.0062
546 SCAB 71 0.0062
547 HEPATOMEGALY 61 0.0062
548 WEIGHT INCREASED 1387 0.0062
549 ANHEDONIA 162 0.0062
550 URINARY RETENTION 205 0.0061
551 FOOT FRACTURE 116 0.0061
552 INSOMNIA 1629 0.0061
553 DIZZINESS 3047 0.0061
554 GENERAL PHYSICAL HEALTH DETERIORATION 704 0.0061
555 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 292 0.0061
556 CHOLESTASIS 116 0.0060
557 PRODUCT ADMINISTRATION ERROR 122 0.0060
558 MUSCULOSKELETAL PAIN 316 0.0060
559 PYREXIA 2086 0.0060
560 HEPATIC STEATOSIS 112 0.0060
561 MOVEMENT DISORDER 193 0.0060
562 HYPOKINESIA 87 0.0060
563 SPLENOMEGALY 70 0.0060
564 DISABILITY 118 0.0060
565 OSTEOPENIA 90 0.0059
566 DISEASE RECURRENCE 279 0.0059
567 PRODUCT PRESCRIBING ERROR 139 0.0058
568 RIB FRACTURE 120 0.0058
569 PRODUCT USE IN UNAPPROVED INDICATION 1438 0.0058
570 THERAPY CHANGE 57 0.0058
571 FALL 1918 0.0058
572 UNINTENDED PREGNANCY 60 0.0057
573 RASH PRURITIC 311 0.0057
574 HYPERBILIRUBINAEMIA 59 0.0057
575 BLOOD SODIUM DECREASED 107 0.0057
576 EAR INFECTION 151 0.0057
577 QUALITY OF LIFE DECREASED 76 0.0057
578 ADVERSE REACTION 75 0.0057
579 LYMPHOPENIA 80 0.0057
580 PETECHIAE 59 0.0056
581 INCREASED TENDENCY TO BRUISE 52 0.0056
582 ADVERSE DRUG REACTION 506 0.0056
583 SEXUAL DYSFUNCTION 66 0.0056
584 DRUG USE DISORDER 47 0.0056
585 INFUSION RELATED REACTION 369 0.0056
586 HYPOAESTHESIA 831 0.0055
587 VISION BLURRED 759 0.0055
588 EATING DISORDER 117 0.0055
589 INTENTIONAL PRODUCT USE ISSUE 481 0.0055
590 SLUGGISHNESS 56 0.0055
591 HEPATIC CIRRHOSIS 103 0.0055
592 HAEMODIALYSIS 46 0.0055
593 HYPOTHYROIDISM 174 0.0054
594 HEPATIC FAILURE 164 0.0054
595 MUSCULAR WEAKNESS 617 0.0054
596 BEDRIDDEN 71 0.0054
597 LIVER FUNCTION TEST ABNORMAL 157 0.0054
598 FACIAL PAIN 48 0.0054
599 PLATELET COUNT INCREASED 70 0.0054
600 INJURY 377 0.0054
601 ASPARTATE AMINOTRANSFERASE INCREASED 284 0.0053
602 PRODUCT DISPENSING ERROR 116 0.0053
603 ARTHROPATHY 296 0.0053
604 OSTEOPOROSIS 219 0.0053
605 THIRST 95 0.0053
606 ATELECTASIS 51 0.0053
607 CYANOSIS 83 0.0053
608 LIP SWELLING 175 0.0052
609 OXYGEN SATURATION DECREASED 294 0.0052
610 ABNORMAL WEIGHT GAIN 64 0.0052
611 MULTI-ORGAN FAILURE 89 0.0051
612 RESPIRATORY DISORDER 154 0.0051
613 FEELING JITTERY 98 0.0051
614 PARAESTHESIA 804 0.0051
615 MOBILITY DECREASED 367 0.0051
616 VENTRICULAR EXTRASYSTOLES 53 0.0051
617 EYE DISCHARGE 53 0.0051
618 VOMITING 2396 0.0051
619 ELECTROLYTE IMBALANCE 59 0.0051
620 HEMIPARESIS 86 0.0051
621 WHEEZING 301 0.0051
622 HYPOPHAGIA 129 0.0050
623 SCAR 86 0.0050
624 SUPRAVENTRICULAR TACHYCARDIA 48 0.0050
625 DECREASED ACTIVITY 54 0.0050
626 HYPOTENSION 1004 0.0050
627 SWOLLEN TONGUE 156 0.0050
628 FREQUENT BOWEL MOVEMENTS 134 0.0050
629 REBOUND EFFECT 56 0.0050
630 MITRAL VALVE INCOMPETENCE 56 0.0049
631 OBSTRUCTIVE AIRWAYS DISORDER 55 0.0049
632 TEMPERATURE INTOLERANCE 51 0.0049
633 NO THERAPEUTIC RESPONSE 60 0.0049
634 HYPOKALAEMIA 226 0.0049
635 URTICARIA 820 0.0049
636 SWELLING FACE 318 0.0049
637 HUNGER 68 0.0049
638 FOOT DEFORMITY 54 0.0049
639 CANDIDA INFECTION 82 0.0049
640 PALLOR 132 0.0048
641 DRUG INEFFECTIVE 6369 0.0048
642 ROAD TRAFFIC ACCIDENT 202 0.0048
643 HEPATIC FUNCTION ABNORMAL 180 0.0048
644 THROAT TIGHTNESS 130 0.0048
645 JOINT STIFFNESS 126 0.0048
646 DYSPHAGIA 455 0.0048
647 LIVER DISORDER 212 0.0048
648 PERIPHERAL COLDNESS 65 0.0047
649 BLOOD LACTATE DEHYDROGENASE INCREASED 75 0.0047
650 CONTUSION 454 0.0047
651 CHOKING 92 0.0047
652 RESPIRATORY DISTRESS 130 0.0047
653 NERVOUS SYSTEM DISORDER 147 0.0047
654 PRODUCT QUALITY ISSUE 639 0.0047
655 MUSCLE TIGHTNESS 76 0.0047
656 HYPERLIPIDAEMIA 56 0.0047
657 SENSORY DISTURBANCE 75 0.0047
658 SCRATCH 49 0.0046
659 FEEDING DISORDER 94 0.0046
660 ACUTE RESPIRATORY FAILURE 89 0.0046
661 INTENTIONAL PRODUCT MISUSE 404 0.0046
662 TENDERNESS 48 0.0046
663 ABNORMAL DREAMS 127 0.0046
664 PRODUCT PRESCRIBING ISSUE 100 0.0046
665 SWELLING 426 0.0045
666 MUSCULOSKELETAL STIFFNESS 398 0.0045
667 IMPAIRED QUALITY OF LIFE 65 0.0045
668 PANCREATITIS 237 0.0045
669 ACUTE KIDNEY INJURY 686 0.0045
670 ORTHOSTATIC HYPOTENSION 78 0.0045
671 CARDIOMEGALY 55 0.0045
672 BLOOD ALKALINE PHOSPHATASE INCREASED 110 0.0044
673 DYSURIA 163 0.0044
674 HEADACHE 2763 0.0044
675 OEDEMA 239 0.0044
676 MUSCLE SPASMS 808 0.0044
677 DRUG WITHDRAWAL SYNDROME NEONATAL 65 0.0044
678 FEELING HOT 269 0.0044
679 FEELING ABNORMAL 1047 0.0044
680 OROPHARYNGEAL PAIN 403 0.0043
681 TINNITUS 200 0.0043
682 CHRONIC KIDNEY DISEASE 330 0.0043
683 HYPERTENSION 919 0.0043
684 PULMONARY FIBROSIS 83 0.0043
685 THERAPEUTIC RESPONSE DECREASED 261 0.0043
686 DYSPEPSIA 421 0.0043
687 PARALYSIS 61 0.0043
688 INSURANCE ISSUE 65 0.0042
689 LYMPHOCYTE COUNT DECREASED 75 0.0042
690 MUSCLE SPASTICITY 52 0.0042
691 PERIPHERAL SWELLING 652 0.0042
692 JOINT INJURY 90 0.0042
693 PRODUCT USE ISSUE 787 0.0042
694 ABDOMINAL PAIN UPPER 857 0.0042
695 ARRHYTHMIA 197 0.0042
696 UNDERDOSE 303 0.0041
697 SEPTIC SHOCK 180 0.0041
698 ILL-DEFINED DISORDER 251 0.0041
699 PRODUCT AVAILABILITY ISSUE 94 0.0041
700 SUBDURAL HAEMATOMA 59 0.0041
701 PANCYTOPENIA 230 0.0041
702 THROMBOCYTOPENIA 459 0.0041
703 OFF LABEL USE 3588 0.0041
704 GASTROINTESTINAL DISORDER 367 0.0041
705 VISUAL IMPAIRMENT 507 0.0041
706 JAUNDICE 110 0.0041
707 WRIST FRACTURE 49 0.0041
708 RESPIRATORY FAILURE 298 0.0041
709 SKIN EXFOLIATION 344 0.0041
710 ANKLE FRACTURE 63 0.0041
711 INTENTIONAL DOSE OMISSION 116 0.0041
712 HYPOAESTHESIA ORAL 61 0.0040
713 DEMENTIA 113 0.0040
714 INTENTIONAL DRUG MISUSE 84 0.0040
715 HYPERSENSITIVITY 745 0.0040
716 DECREASED APPETITE 920 0.0040
717 INFUSION SITE PAIN 51 0.0040
718 FATIGUE 3079 0.0040
719 HYPERHIDROSIS 508 0.0039
720 NERVOUSNESS 206 0.0039
721 DISCOMFORT 239 0.0039
722 PRODUCT TASTE ABNORMAL 53 0.0039
723 GASTROENTERITIS VIRAL 70 0.0039
724 THERAPEUTIC RESPONSE UNEXPECTED 172 0.0038
725 PANCREATITIS ACUTE 86 0.0038
726 NAUSEA 3028 0.0038
727 DERMATITIS 80 0.0038
728 ALOPECIA 747 0.0038
729 ORAL PAIN 85 0.0038
730 HIP ARTHROPLASTY 58 0.0038
731 CARPAL TUNNEL SYNDROME 53 0.0038
732 DYSSTASIA 110 0.0038
733 ASTHENIA 1400 0.0037
734 MUSCLE ATROPHY 47 0.0037
735 PHARYNGEAL OEDEMA 57 0.0037
736 BACTERIAL INFECTION 69 0.0037
737 BLOOD POTASSIUM DECREASED 111 0.0037
738 BACK DISORDER 60 0.0037
739 ABDOMINAL DISCOMFORT 615 0.0037
740 UPPER LIMB FRACTURE 73 0.0037
741 HYPOXIA 129 0.0037
742 RETCHING 78 0.0037
743 URINARY TRACT INFECTION 622 0.0036
744 ORAL CANDIDIASIS 48 0.0036
745 PERICARDIAL EFFUSION 84 0.0036
746 HAEMATOCRIT DECREASED 72 0.0036
747 CYST 45 0.0036
748 MENORRHAGIA 71 0.0036
749 SKIN DISCOLOURATION 166 0.0036
750 RED BLOOD CELL COUNT DECREASED 103 0.0036
751 INFLUENZA LIKE ILLNESS 292 0.0035
752 HEART RATE INCREASED 351 0.0035
753 HYPOCALCAEMIA 67 0.0035
754 SYNCOPE 354 0.0035
755 EYE PAIN 199 0.0035
756 INTERVERTEBRAL DISC PROTRUSION 77 0.0035
757 BLOOD TRIGLYCERIDES INCREASED 62 0.0035
758 NEUTROPHIL COUNT DECREASED 143 0.0035
759 WEIGHT DECREASED 979 0.0035
760 KNEE ARTHROPLASTY 73 0.0035
761 UPPER RESPIRATORY TRACT INFECTION 160 0.0035
762 PRURITUS 1328 0.0035
763 HEAD DISCOMFORT 61 0.0034
764 CONSTIPATION 742 0.0034
765 ULCER 54 0.0034
766 LIMB DISCOMFORT 105 0.0034
767 INTERNATIONAL NORMALISED RATIO INCREASED 96 0.0034
768 JOINT SWELLING 404 0.0033
769 RHEUMATOID ARTHRITIS 379 0.0033
770 NEPHROLITHIASIS 153 0.0033
771 PRODUCT DOSE OMISSION ISSUE 980 0.0033
772 NEURALGIA 81 0.0033
773 PRODUCT PHYSICAL ISSUE 67 0.0033
774 ABDOMINAL PAIN 772 0.0033
775 PNEUMONIA 1067 0.0033
776 SPINAL FRACTURE 66 0.0033
777 ERYTHEMA 670 0.0033
778 HERNIA 63 0.0033
779 ACTIVITIES OF DAILY LIVING IMPAIRED 64 0.0032
780 CHILLS 377 0.0032
781 THERAPY CESSATION 165 0.0032
782 PALPITATIONS 376 0.0032
783 ADVERSE EVENT 295 0.0032
784 PRODUCT USE COMPLAINT 50 0.0032
785 MALAISE 1388 0.0032
786 NEUTROPENIA 430 0.0032
787 ERECTILE DYSFUNCTION 81 0.0032
788 ECZEMA 165 0.0031
789 SKIN DISORDER 105 0.0031
790 BLOOD PRESSURE DECREASED 209 0.0031
791 OCULAR HYPERAEMIA 149 0.0031
792 LIMB INJURY 85 0.0031
793 BURNING SENSATION 219 0.0031
794 ASTHMA 352 0.0031
795 CHEST PAIN 576 0.0031
796 ANGIOEDEMA 137 0.0031
797 CELLULITIS 156 0.0031
798 HAEMATOMA 80 0.0031
799 IMMUNODEFICIENCY 46 0.0031
800 FRACTURE 58 0.0031
801 TOOTHACHE 55 0.0030
802 DRUG EFFECT LESS THAN EXPECTED 45 0.0030
803 SURGERY 178 0.0030
804 BLOOD BILIRUBIN INCREASED 82 0.0030
805 RENAL FAILURE 403 0.0030
806 DEHYDRATION 404 0.0030
807 FEELING COLD 84 0.0030
808 ABDOMINAL DISTENSION 314 0.0030
809 COAGULOPATHY 50 0.0030
810 PROTEINURIA 57 0.0030
811 POLLAKIURIA 125 0.0030
812 NASOPHARYNGITIS 549 0.0030
813 SINUSITIS 301 0.0029
814 PRODUCT DOSE OMISSION IN ERROR 83 0.0029
815 WHITE BLOOD CELL COUNT DECREASED 317 0.0029
816 END STAGE RENAL DISEASE 53 0.0029
817 EYE DISORDER 95 0.0029
818 CYSTITIS 92 0.0029
819 DRY EYE 144 0.0029
820 ILLNESS 297 0.0029
821 BLINDNESS 117 0.0029
822 VIRAL INFECTION 95 0.0029
823 HEPATOTOXICITY 63 0.0028
824 STAPHYLOCOCCAL INFECTION 93 0.0028
825 BLOOD PRESSURE ABNORMAL 56 0.0028
826 SEPSIS 314 0.0028
827 PRESYNCOPE 68 0.0028
828 ABASIA 69 0.0028
829 MUCOSAL INFLAMMATION 73 0.0028
830 BRONCHITIS 205 0.0028
831 EYE SWELLING 103 0.0028
832 CHROMATURIA 62 0.0027
833 HYPOGLYCAEMIA 133 0.0027
834 GASTRITIS 72 0.0027
835 UNEVALUABLE EVENT 207 0.0027
836 PLEURAL EFFUSION 166 0.0027
837 OEDEMA PERIPHERAL 332 0.0027
838 MULTIPLE SCLEROSIS 130 0.0027
839 SKIN FISSURES 53 0.0027
840 DRUG PRESCRIBING ERROR 52 0.0027
841 FLUSHING 273 0.0027
842 COLD SWEAT 47 0.0027
843 DYSGEUSIA 198 0.0027
844 MYALGIA 452 0.0027
845 HEART RATE IRREGULAR 60 0.0027
846 DRUG WITHDRAWAL SYNDROME 233 0.0027
847 BLOOD CREATININE INCREASED 173 0.0026
848 ABDOMINAL PAIN LOWER 67 0.0026
849 VISUAL ACUITY REDUCED 88 0.0026
850 LABORATORY TEST ABNORMAL 78 0.0026
851 DIARRHOEA 1705 0.0026
852 DEAFNESS 69 0.0026
853 PAIN 1608 0.0026
854 DRUG EFFECT INCOMPLETE 95 0.0026
855 DIABETES MELLITUS 199 0.0026
856 KIDNEY INFECTION 51 0.0026
857 PRURITUS GENERALISED 56 0.0026
858 PLATELET COUNT DECREASED 276 0.0026
859 ARTHRALGIA 1068 0.0026
860 EMOTIONAL DISTRESS 310 0.0026
861 PRODUCT DOSE OMISSION 167 0.0026
862 HIP FRACTURE 82 0.0025
863 THERAPY INTERRUPTED 181 0.0025
864 INFECTION 364 0.0025
865 INTESTINAL OBSTRUCTION 94 0.0025
866 BACK PAIN 577 0.0025
867 COVID-19 434 0.0025
868 BLOOD PRESSURE FLUCTUATION 59 0.0025
869 PAIN IN EXTREMITY 719 0.0024
870 TOOTH DISORDER 54 0.0024
871 MULTIPLE SCLEROSIS RELAPSE 166 0.0024
872 RESPIRATORY TRACT INFECTION 63 0.0024
873 CLOSTRIDIUM DIFFICILE INFECTION 52 0.0024
874 DYSPNOEA 1348 0.0024
875 RENAL IMPAIRMENT 200 0.0024
876 DRUG ADMINISTRATION ERROR 73 0.0024
877 DERMATITIS ATOPIC 125 0.0024
878 HOSPITALISATION 364 0.0024
879 BLOOD PRESSURE SYSTOLIC INCREASED 46 0.0024
880 RENAL FAILURE ACUTE 100 0.0024
881 HEART RATE DECREASED 82 0.0023
882 MENSTRUATION IRREGULAR 62 0.0023
883 CHEST DISCOMFORT 235 0.0023
884 RENAL INJURY 68 0.0023
885 BLOOD PRESSURE INCREASED 345 0.0023
886 PULMONARY HYPERTENSION 47 0.0023
887 PULMONARY OEDEMA 101 0.0023
888 THERAPEUTIC RESPONSE SHORTENED 74 0.0022
889 TRANSIENT ISCHAEMIC ATTACK 75 0.0022
890 DYSPHONIA 130 0.0022
891 PRODUCTIVE COUGH 106 0.0022
892 BONE MARROW FAILURE 45 0.0022
893 ANAEMIA 422 0.0022
894 EYE IRRITATION 127 0.0022
895 INFLUENZA 245 0.0022
896 HYPERGLYCAEMIA 80 0.0022
897 LACTIC ACIDOSIS 71 0.0022
898 COUGH 608 0.0022
899 RHINORRHOEA 139 0.0021
900 FAECES DISCOLOURED 46 0.0021
901 DRUG EFFECT DECREASED 114 0.0021
902 HYPOACUSIS 91 0.0021
903 ARTHRITIS 165 0.0021
904 DIABETIC KETOACIDOSIS 50 0.0021
905 CHOLELITHIASIS 68 0.0021
906 PULMONARY EMBOLISM 196 0.0021
907 EYE PRURITUS 69 0.0021
908 HAEMATEMESIS 52 0.0020
909 ANAPHYLACTIC REACTION 113 0.0020
910 HAEMOGLOBIN DECREASED 209 0.0020
911 PNEUMONITIS 55 0.0020
912 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 364 0.0020
913 GASTRIC DISORDER 69 0.0020
914 RECTAL HAEMORRHAGE 86 0.0020
915 RENAL DISORDER 93 0.0020
916 CATARACT 118 0.0020
917 PAIN IN JAW 56 0.0020
918 FLATULENCE 112 0.0020
919 LACRIMATION INCREASED 59 0.0020
920 ASCITES 57 0.0019
921 SKIN ULCER 50 0.0019
922 NEUROPATHY PERIPHERAL 183 0.0019
923 VAGINAL HAEMORRHAGE 83 0.0019
924 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 56 0.0019
925 ACNE 144 0.0019
926 BONE PAIN 111 0.0019
927 FLUID RETENTION 96 0.0019
928 EPISTAXIS 140 0.0019
929 HOT FLUSH 141 0.0019
930 PSORIASIS 243 0.0019
931 HERPES ZOSTER 106 0.0018
932 HAEMATURIA 62 0.0018
933 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 364 0.0018
934 INTERSTITIAL LUNG DISEASE 86 0.0018
935 THROMBOSIS 142 0.0018
936 DYSPNOEA EXERTIONAL 65 0.0017
937 FUNGAL INFECTION 57 0.0017
938 DEEP VEIN THROMBOSIS 111 0.0017
939 SKIN BURNING SENSATION 122 0.0017
940 INCORRECT DOSE ADMINISTERED 388 0.0017
941 DRUG DOSE OMISSION 276 0.0017
942 COLITIS 63 0.0017
943 WRONG TECHNIQUE IN DRUG USAGE PROCESS 60 0.0016
944 NASAL CONGESTION 97 0.0016
945 HAEMATOCHEZIA 91 0.0016
946 BONE DENSITY DECREASED 50 0.0016
947 CEREBRAL HAEMORRHAGE 57 0.0016
948 THROAT IRRITATION 70 0.0016
949 HAEMORRHAGE 163 0.0016
950 CARDIAC FAILURE 123 0.0015
951 ACUTE MYOCARDIAL INFARCTION 45 0.0015
952 OSTEONECROSIS 50 0.0015
953 DEVICE DISLOCATION 66 0.0015
954 CARDIAC DISORDER 142 0.0015
955 INJECTION SITE MASS 56 0.0015
956 ATRIAL FIBRILLATION 147 0.0015
957 EXPIRED PRODUCT ADMINISTERED 50 0.0015
958 CEREBROVASCULAR ACCIDENT 254 0.0015
959 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 78 0.0015
960 COLITIS ULCERATIVE 66 0.0015
961 HYPERKALAEMIA 50 0.0014
962 DRY SKIN 190 0.0014
963 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 101 0.0014
964 INJECTION SITE REACTION 96 0.0014
965 DEVICE BREAKAGE 54 0.0013
966 MYELOSUPPRESSION 47 0.0013
967 DRUG DEPENDENCE 207 0.0013
968 BLOOD GLUCOSE INCREASED 230 0.0012
969 DEATH 1035 0.0012
970 EXTRA DOSE ADMINISTERED 47 0.0012
971 BLOOD GLUCOSE DECREASED 55 0.0011
972 INJECTION SITE BRUISING 91 0.0011
973 MYOCARDIAL INFARCTION 195 0.0011
974 ACCIDENTAL EXPOSURE TO PRODUCT 115 0.0011
975 NO ADVERSE EVENT 202 0.0011
976 FEBRILE NEUTROPENIA 72 0.0011
977 GASTROINTESTINAL HAEMORRHAGE 89 0.0011
978 INJECTION SITE SWELLING 80 0.0010
979 INJECTION SITE PRURITUS 68 0.0010
980 DISEASE PROGRESSION 116 0.0010
981 DEVICE ISSUE 87 0.0010
982 NEOPLASM MALIGNANT 63 0.0009
983 INJECTION SITE PAIN 274 0.0009
984 INJECTION SITE HAEMORRHAGE 66 0.0008
985 INJECTION SITE ERYTHEMA 102 0.0008
986 DEVICE EXPULSION 52 0.0008
987 DEVICE MALFUNCTION 56 0.0008
988 BREAST CANCER 73 0.0008
989 CARDIAC FAILURE CONGESTIVE 59 0.0007
990 MALIGNANT NEOPLASM PROGRESSION 56 0.0005